E-ISSN 2231-3206 | ISSN 2320-4672
 
2026, Vol: 16, Issue: 1
16 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

NJPPP Manuscript Submission Form
Title Page

Review Article
Online Published: 05 Jun 2013
 


Newer anti-platelet and anti-thrombotic drugs on the horizon

Ajai Garg, Anjana Pandey, Pranab Oza, Mridul Chaturvedi.


Cited By:6

Abstract
Aspirin is a highly successful antiplatelet drug & still retains its status as the 'front-line' antiplatelet drug; however, increased understanding of platelet biology has led to the development of new antiplatelet drugs that are potentially more effective. Now, more researches in platelet biology has led to this fact that there are more than 90 other metabolic pathways leading to platelet aggregation that are independent of arachidonic acid and therefore not inhibited by aspirin, hence, several more drugs are being developed, aimed at controlling different phases of platelet function such as platelet aggregation & adhesion. The newer drugs now offer potentially greater and more specific control over platelet function. Definitely, these drugs are going to be significantly more expensive than aspirin, and their eventual role in the clinical arena will ultimately depend on both their efficacy and their cost-effectiveness. As we approach the next millennium, it is envisaged that our increased understanding of platelet function, coupled with advances in technology and drug manufacture, will result in even greater improvements in the therapeutic control of platelet thrombus.

Key words: Prasugrel; Ticagrelor; Antiplatelet Drug Therapy; Pathophysiology of Platelet Aggregation


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ajai Garg
Articles by Anjana Pandey
Articles by Pranab Oza
Articles by Mridul Chaturvedi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Garg A, Pandey A, Oza P, Chaturvedi M. Newer anti-platelet and anti-thrombotic drugs on the horizon. Natl J Physiol Pharm Pharmacol. 2013; 3(2): 105-110. doi:10.5455/njppp.2013.3.090420131

Web Style

Garg A, Pandey A, Oza P, Chaturvedi M. Newer anti-platelet and anti-thrombotic drugs on the horizon. https://www.njppp.com/?mno=9978 [Access: November 02, 2025]. doi:10.5455/njppp.2013.3.090420131

AMA (American Medical Association) Style

Garg A, Pandey A, Oza P, Chaturvedi M. Newer anti-platelet and anti-thrombotic drugs on the horizon. Natl J Physiol Pharm Pharmacol. 2013; 3(2): 105-110. doi:10.5455/njppp.2013.3.090420131


Vancouver/ICMJE Style

Garg A, Pandey A, Oza P, Chaturvedi M. Newer anti-platelet and anti-thrombotic drugs on the horizon. Natl J Physiol Pharm Pharmacol. (2013), [cited November 02, 2025]; 3(2): 105-110. doi:10.5455/njppp.2013.3.090420131


Harvard Style

Garg, A., Pandey, . A., Oza, . P. & Chaturvedi, . M. (2013) Newer anti-platelet and anti-thrombotic drugs on the horizon. Natl J Physiol Pharm Pharmacol, 3 (2), 105-110. doi:10.5455/njppp.2013.3.090420131


Turabian Style

Garg, Ajai, Anjana Pandey, Pranab Oza, and Mridul Chaturvedi. 2013. Newer anti-platelet and anti-thrombotic drugs on the horizon. National Journal of Physiology, Pharmacy and Pharmacology, 3 (2), 105-110. doi:10.5455/njppp.2013.3.090420131


Chicago Style

Garg, Ajai, Anjana Pandey, Pranab Oza, and Mridul Chaturvedi. "Newer anti-platelet and anti-thrombotic drugs on the horizon." National Journal of Physiology, Pharmacy and Pharmacology 3 (2013), 105-110. doi:10.5455/njppp.2013.3.090420131


MLA (The Modern Language Association) Style

Garg, Ajai, Anjana Pandey, Pranab Oza, and Mridul Chaturvedi. "Newer anti-platelet and anti-thrombotic drugs on the horizon." National Journal of Physiology, Pharmacy and Pharmacology 3.2 (2013), 105-110. Print. doi:10.5455/njppp.2013.3.090420131


APA (American Psychological Association) Style

Garg, A., Pandey, . A., Oza, . P. & Chaturvedi, . M. (2013) Newer anti-platelet and anti-thrombotic drugs on the horizon. National Journal of Physiology, Pharmacy and Pharmacology, 3 (2), 105-110. doi:10.5455/njppp.2013.3.090420131


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

About the JournalThe National Journal of Physiology, Pharmacy and Pharmacology (NJPPP) is a peer-reviewed, open-access journal dedicated to advancing rese ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information

Eldaghayes Publisher

www.eldaghayes.com 
 

All correspondence should be addressed to:

National Journal of Physiology, Pharmacy and Pharmacology

Email: info@eldaghayes.com